25 Sep 2025
Genetics is no longer reserved for rare conditions or niche specialties. Genomic insights are shaping real-time treatment decisions at health systems nationwide, but expanding this impact across all clinical settings still presents major hurdles.
In this live panel discussion, leaders from Swedish Cancer Institute, Labcorp, and genetics media offered their perspectives on scaling genetic services across diverse settings and preparing for the next era of precision medicine. They shared real-world strategies to expand access, streamline workflows, and strengthen collaboration across the care continuum.